Using protease inhibitors in antigen presentation assays

Methods in Molecular Biology

Volumn 960, Issue , 2013, Pages 31-39

  Basler, Michael ^a,b   Groettrup, Marcus ^a,b  

^a UNIVERSITY OF KONSTANZ   (Switzerland)

^b UNIVERSITY OF KONSTANZ   (Germany)

Author keywords

Antigen presentation; Antigen processing; Inhibitor; Intracellular cytokine staining; LacZassay; MHC I surface staining; Protease; Proteasome; T cell hybridomas; T cell lines

Indexed keywords

LIGAND; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PROTEASOME; PROTEINASE INHIBITOR; CYTOKINE; EPITOPE; HLA A ANTIGEN;

ANIMAL CELL; ANTIGEN PRESENTATION; ARTICLE; ASSAY; CELL NUCLEUS; CYTOPLASM; CYTOSOL; CYTOTOXIC T LYMPHOCYTE; ENDOPLASMIC RETICULUM; FLOW CYTOMETRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; ANIMAL; C57BL MOUSE; CELL LINE; CYTOLOGY; DRUG EFFECT; FEMALE; GENETICS; HYBRIDOMA; IMMUNOLOGY; INTRACELLULAR SPACE; LACTOSE OPERON; MALE; METABOLISM; METHODOLOGY; STAINING;

ANIMALS; ANTIGEN PRESENTATION; CELL LINE; CYTOKINES; CYTOLOGICAL TECHNIQUES; EPITOPES, T-LYMPHOCYTE; FEMALE; FLOW CYTOMETRY; HLA-A ANTIGENS; HYBRIDOMAS; INTRACELLULAR SPACE; LAC OPERON; MALE; MICE; MICE, INBRED C57BL; PROTEASE INHIBITORS; STAINING AND LABELING; T-LYMPHOCYTES, CYTOTOXIC;

MLCS; MLOWN;

EID: 84879305389     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-62703-218-6_3     Document Type: Article

References (19)

1. Beninga J, Rock KL, Goldberg AL (1998) Interferon-gamma can stimulate post-proteasomal trimming of the N terminus of an antigenic peptide by inducing leucine aminopeptidase. J Biol Chem 273:18734-18742
2. Parmentier N, Stroobant V, Colau D et al (2010) Production of an antigenic peptide by insulindegrading enzyme. Nat Immunol 11:449-454
3. Stoltze L, Schirle M, Schwarz G et al (2000) Two new proteases in the MHC class I processing pathway. Nat Immunol 1:413-418
4. Saric T, Beninga J, Graef CI et al (2001) Major histocompatibility complex class I-presented antigenic peptides are degraded in cytosolic extracts primarily by thimet oligopeptidase. J Biol Chem 276:36474-36481
5. York IA, Mo AXY, Lemerise K et al (2003) The cytosolic endopeptidase, thimet oligopeptidase, destroys antigenic peptides and limits the extent of MHC class I antigen presentation. Immunity 18:429-440
6. Kessler JH, Khan S, Seifert U et al (2011) Antigen processing by nardilysin and thimet oligopeptidase generates cytotoxic T cell epitopes. Nat Immunol 12:45-53
7. Geier E, Pfeifer G, Wilm M et al (1999) A giant protease with potential to substitute for some functions of the proteasome. Science 283: 978-981
8. Seifert U, Maranon C, Shmueli A et al (2003) An essential role for tripeptidyl peptidase in the generation of an MHC class I epitope. Nat Immunol 4:375-379
9. Reits E, Neijssen J, Herberts C et al (2004) A major role for TPPII in trimming proteasomal degradation products for MHC class I antigen presentation. Immunity 20:495-506
10. Basler M, Groettrup M (2007) No essential role for tripeptidyl peptidase II for the processing of LCMV-derived T cell epitopes. Eur J Immunol 37:896-904
11. York IA, Chang SC, Saric T et al (2002) The ER aminopeptidase ERAP1 enhances or limits antigen presentation by trimming epitopes to 8-9 residues. Nat Immunol 3:1177-1184
12. Saric T, Chang SC, Hattori A et al (2002) An IFN-gamma-induced aminopeptidase in the ER, ERAP1, trims precursors to MHC class I-presented peptides. Nat Immunol 3: 1169-1176
13. Saveanu L, Carroll O, Lindo V et al (2005) Concerted peptide trimming by human ERAP1 and ERAP2 aminopeptidase complexes in the endoplasmic reticulum. Nat Immunol 6: 689-697
14. Saveanu L, Carroll O, Weimershaus M et al (2009) IRAP identi fi es an endosomal compartment required for MHC class I cross-presentation. Science 325:213-217
15. Muchamuel T, Basler M, Aujay MA et al (2009) A selective inhibitor of the immunoproteasome subunit LMP7 blocks cytokine production and attenuates progression of experimental arthritis. Nat Med 15:781-787
16. Schwarz K, van den Broek M, de Giuli R et al (2000) The use of LCMV-speci fi c Tcell hybridomas for the quantitative analysis of MHC class I restricted antigen presentation. J Immunol Methods 237:199-202
17. Sanderson S, Shastri N (1994) LacZ inducible, antigen/MHC-specific T cell hybrids. Int Immunol 6:369-376
18. Mariotti S, Nisini R (2009) Generation of human T cell clones. Methods Mol Biol 514: 65-93
19. Basler M, Moebius J, Elenich L et al (2006) An altered T cell repertoire in MECL-1-deficient mice. J Immunol 176:6665-6672